Summit Therapeutics - ADR Shareholding Patterns
$17.36
As on 30-Sep-2026 14:39EDT
Market cap
$12,453 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %
$17.36
As on 30-Sep-2026 14:39EDT
Market cap
$12,453 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %